Empiric antibiotic therapy for Mycoplasma pneumoniae pneumonia in children: A Pro/Con Discussion [0.03%]
儿童肺炎支原体肺炎经验性抗生素治疗：正方与反方讨论
Elizabeth C Lloyd,Joshua Wolf
Elizabeth C Lloyd
Mycoplasma pneumoniae is a common respiratory pathogen of increasing clinical interest as cases have recently risen in the United States and worldwide following a period of reduced activity during the COVID-19 pandemic. While most cases are...
A Pediatric Infectious Diseases Asynchronous eConsult Program: An Evaluation of Content, Impact Assessment and User Feedback [0.03%]
儿科传染病异步e会诊项目：内容、影响评估及用户反馈的评价
Vandana L Madhavan,Lulu Xu,Ann M Murray et al.
Vandana L Madhavan et al.
Background: Asynchronous electronic consults, or eConsults, are a novel way for pediatric infectious disease (PID) physicians to provide non-urgent specialty advice to other clinicians. We sought to evaluate the first fiv...
Monomicrobial Rothia spp. Bloodstream Infections in Pediatric Patients and Literature Review [0.03%]
儿童患者单微生物放线菌血流感染及文献回顾
Joshua D Green,Preeti Jaggi,Mark D Gonzalez et al.
Joshua D Green et al.
We examined 51 monomicrobial Rothia spp. blood cultures from 2015 to 2024. Seventy-one percent occurred in cancer/HCT patients, of which 97% were treated as true BSIs and 78% followed recent broad-spectrum antibiotics. Prolonged (>4 day) fe...
Immunogenicity and safety of a 2 + 1 DTPa priming schedule in Australian infants and the impact of maternally derived antibodies on pertussis antibody responses up to four years of age [0.03%]
在澳大利亚婴儿中，DTPa基础免疫程序(2+1)的免疫原性和安全性以及母体抗体对4岁以内儿童百日咳抗体应答的影响
Sonia M McAlister,Alexandra Dierig,Anita H J van den Biggelaar et al.
Sonia M McAlister et al.
We assessed the impact of maternally derived pertussis antibodies on infant responses to a 2 + 1 vaccine schedule (6 weeks, 12 weeks, and 12 months). Infants with baseline antibodies showed lower IgG responses following the primary vaccinat...
Huong Q Nguyen,Oluwakemi D Alonge,Kayla E Hanson et al.
Huong Q Nguyen et al.
Background: The cell culture-based inactivated influenza vaccine (ccIIV) was first approved for use in children aged 4 through 17 years in 2016 in the United States. The approved age indication for ccIIV was expanded to i...
Implementation and reimbursement of G0545 in infectious diseases billing at a freestanding pediatric hospital [0.03%]
儿童独立儿科医院感染科G0545项目的实施及其报销政策分析
Caitlin Naureckas Li,Kathleen Murtagh,Erin Claussen et al.
Caitlin Naureckas Li et al.
Use and Stewardship of Molecular Testing for Diagnosis of Infectious Diseases: A Cross-Sectional Survey [0.03%]
分子检测诊断传染病的应用和管理：横断面调查研究
Caitlin Naureckas Li,Jennifer A Blumenthal,Anna C Sick-Samuels
Caitlin Naureckas Li
Untargeted molecular tests are increasingly available for diagnosis of infectious diseases. In this national survey, plasma metagenomic next-generation sequencing had widespread use (89.8%), but disparate frequency from a few times ever (18...
Improving Pass Rates For the Pediatric Infectious Diseases Initial Certifying Exam (ICE) Would Be The "ICING On The Cake" [0.03%]
提高儿科传染病专业初始认证考试通过率 "为蛋糕添上 icing"
Ian C Michelow
Ian C Michelow
Factors associated with pediatric COVID-19 mortality: A Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study [0.03%]
儿童COVID-19死亡相关因素：加拿大儿科感染协作网(PICNIC)研究
Michael Prodanuk,Michelle Barton,Julie Autmizguine et al.
Michael Prodanuk et al.
Factors associated with COVID-19 mortality are not well characterized in children. This Canadian-Caribbean case-control study identified 26 children who died of COVID-19 and matched them to 78 children hospitalized with COVID-19 who survive...